295 related articles for article (PubMed ID: 16307509)
1. Prevention of mother-to-child transmission of HIV: treatment options.
McIntyre J
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):971-80. PubMed ID: 16307509
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
3. Preventing mother-to-child transmission of HIV: successes and challenges.
McIntyre J
BJOG; 2005 Sep; 112(9):1196-203. PubMed ID: 16101596
[TBL] [Abstract][Full Text] [Related]
4. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
5. The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV.
Chama C; Gashau W; Oguche S
J Obstet Gynaecol; 2007 Feb; 27(2):134-7. PubMed ID: 17454457
[TBL] [Abstract][Full Text] [Related]
6. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
7. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
9. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
[TBL] [Abstract][Full Text] [Related]
10. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
11. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.
Plipat T; Naiwatanakul T; Rattanasuporn N; Sangwanloy O; Amornwichet P; Teeraratkul A; Ungchusak K; Mock P; Levine W; McConnell MS; Simonds R; Culnane M
AIDS; 2007 Jan; 21(2):145-51. PubMed ID: 17197804
[TBL] [Abstract][Full Text] [Related]
12. The use of highly active antiretroviral therapy for the prevention of mother-to-child transmission of the human immunodeficiency virus in Nigeria.
Chama CM; Bello M; Ajayi BA; Zarma S; Gashau W
J Obstet Gynaecol; 2010 May; 30(4):362-6. PubMed ID: 20455718
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
14. Preventing mother-to-child transmission of HIV.
Mnyani CN; McIntyre JA
BJOG; 2009 Oct; 116 Suppl 1():71-6. PubMed ID: 19740178
[TBL] [Abstract][Full Text] [Related]
15. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings.
Ekouevi DK; Tonwe-Gold B; Dabis F
AIDS Read; 2005 Sep; 15(9):479-80, 487-93. PubMed ID: 16170877
[TBL] [Abstract][Full Text] [Related]
16. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
Shapiro RL; Thior I; Gilbert PB; Lockman S; Wester C; Smeaton LM; Stevens L; Heymann SJ; Ndung'u T; Gaseitsiwe S; Novitsky V; Makhema J; Lagakos S; Essex M
AIDS; 2006 Jun; 20(9):1281-8. PubMed ID: 16816557
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 drug resistance and mother-to-child transmission.
Morris L; Pillay C; Gray G; McIntyre J
SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of perinatal HIV.
Capparelli E; Rakhmanina N; Mirochnick M
Semin Fetal Neonatal Med; 2005 Apr; 10(2):161-75. PubMed ID: 15701581
[TBL] [Abstract][Full Text] [Related]
19. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
20. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
